Chris Silvia is Vice President, Data Sciences and Corporate IT, and has more than 25 years of experience in the pharmaceutical and biotechnology industries. He is responsible for all IT and business technology activities at OmniAb. Dr. Silvia began his employment with Icagen, Inc. in Molecular Biology and Biochemistry, where he cloned and expressed ion channels and holds several patents related to ion channel molecular biology. Over the course of his career, Dr. Silvia has had increasing levels of responsibility in the information technology and informatics areas, including during Icagen, Inc.’s tenure as part of Pfizer, where he managed global rollout of data management tools. Dr. Silvia received a Doctorate in Pharmacology from Ohio State University and a Bachelor of Science in Pharmacy from the University of Rhode Island and completed postdoctoral training at the Howard Hughes Medical Institute at Duke University.
